NTV Asset Management LLC Has $7.18 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

NTV Asset Management LLC trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 54,308 shares of the financial services provider’s stock after selling 620 shares during the period. iShares Biotechnology ETF comprises approximately 0.9% of NTV Asset Management LLC’s portfolio, making the stock its 25th largest holding. NTV Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $7,180,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth about $29,000. Highline Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth about $30,000. HHM Wealth Advisors LLC grew its position in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares during the period. Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth about $36,000. Finally, Newbridge Financial Services Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $33,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.4 %

NASDAQ:IBB opened at $136.55 on Monday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business’s 50-day simple moving average is $135.73 and its 200-day simple moving average is $140.93.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.